ALSO NOTED: Amgen, Abgenix stock soars; Cytori, Olympus collaborate; GSK builds new facility; and much more...

> On the heels of yesterday's announcement of Amgen and Abgenix's successful colorectal study, both companies stock prices soared while rival ImClone enjoyed less success. Article

> Cytori Therapeutics and Olympus announced that they will collaborate to develop and manufacture systems for stem and regenerative cell therapies. Release

> GSK is planning to invest $115 million in a new laboratory facility in Singapore. The purpose of the site will be to convert experimental molecules into medicines in order to bolster GSK's internal pipeline. Release

> UK biotech Biopure as received approval to begin phase 2 trials for experimental  oxygen therapeutic Hemopure, a therapy for patients healing from lower limb amputation. Report

And Finally... Researchers say that combining aspirin with the drug clopidogrel (Sanofi-Aventis' Plavix) could prevent thousands of deaths. Report